Latest Antitussives Stories
Kentucky-based Xanodyne Pharmaceuticals has pulled its popular narcotic painkiller, Darvon, from the drug market because it may cause fatal heart rhythms.
SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S.
Cold Buster, New Product from Buster Brands, Emerges in the Wake of Dextromethorphan Debate On the heels of an FDA Advisory Committee Meeting evaluating safety concerns of cold medication dextromethorphan, Buster Brands announces Cold Buster, a new product with proven efficacy and no risks of abuse. Morristown, NJ (Vocus) October 19, 2010 (Vocus) October 19, 2010 -- On September 14, 2010, the FDA Drug Safety and Risk Management Advisory Committee met to evaluate the safety of...
It might be painful but it's time to say good riddance to codeine as a pain reliever.
NEWTOWN SQUARE, Pa., Sept. 17 /PRNewswire/ -- Launching now in national pharmacy chains is ChestalÂ®, a natural cough syrup free of dextromethorphan from Boiron, the world leader in homeopathic medicines.
Survey of Police and Teachers: Alcohol and Marijuana Most Serious Substance Abuse Facing Teens NEW YORK, Sept.
Upcoming FDA Hearing on Abuse of Cough and Cold Medications Misses the Mark NEW YORK, Sept.
US health regulators are working out possible restrictions on popular cough suppressants in hopes to stop cases of abuse that send thousands of people to the hospital each year.
HALIFAX, Canada, July 16, 2010 /PRNewswire-FirstCall/ -- Gammon Gold Inc. ("Gammon") (TSX:GAM and NYSE:GRS): Gammon is pleased to announce that it has completed the non-brokered private placement with Corex Gold Corporation ("Corex") (TSXV:CGE) announced on July 8, 2010.